Europe Monoclonal Antibodies Market Share, Growth, Trends, and Forecasts (20162021)
Europe Monoclonal Antibodies Market by Source (Murine, Chimeric, Humanized, Human) by Indication, by End-User (Hospitals/Clinics, Research Institute, Diagnostic Laboratories) by Application (Medical, Experimental).
(EMAILWIRE.COM, January 30, 2018 ) The Europe Monoclonal Antibodies Market was worth $26860.7439 million in 2016 and estimated to be growing at a CAGR of 5.32%, to reach $34807.46 million by 2021.
View report: http://www.marketdataforecast.com/market-reports/europe-monoclonal-antibodies-market-1186/
MAb`s are antibodies produced by a single clone of cells consisting of identical antibody molecules. Monoclonal Antibodies have various diagnostic and therapeutic applications, especially in cancer. Apart from these mAb`s are also useful in protein purification. Growth in sales of currently approved monoclonal antibody products, along with 300 monoclonal antibody products currently in development, will show significant growth in sales of mAb products in the coming five years
Download free sample report: http://www.marketdataforecast.com/market-reports/europe-monoclonal-antibodies-market-1186/request-sample
Europe Monoclonal Antibodies market is driven by increasing Research and development activities, owing to introduction of advanced methods for mAb production. Major pharmaceutical companies are building their own product pipeline for the development of new molecules. Growing consumer awareness about various benefits and applications of mAb is also a major driving factor for the market growth. However huge cost and time associated with the identification and development, and stringent regulatory framework are the key restraining factors for the market growth.
Europe Monoclonal Antibodies is segmented by Source, Indication, End User and Application. On the basis of source market is categorized into Murine, Chimeric, Humanized and Human. By source Human mAb`s account for the largest share of the market. Based on Application the market is Segmented to cancer, Auto immune diseases, Infectious diseases, Cardiovascular diseases, CNS disorders and others. Cancer Vaccines are further sub segmented into Blood Cancer, Breast Cancer, Colorectal Cancer, Lung Cancer, Pancreatic Cancer and Others. On the basis of end user, the market is segmented into Hospitals/Clinics, Research Institute and Diagnostic Laboratories. Hospitals is the largest end user segment accounting for a share of approximately XX%. By application global monoclonal antibodies market is segmented into medical and experimental. Based on experimental the market is further sub segmented into Western Blot, ELISA, Radioimmune Assays, Immunofluorescence and others.
Inquire before buying: http://www.marketdataforecast.com/market-reports/europe-monoclonal-antibodies-market-1186/inquire
Geographically Europe monoclonal antibodies market is segmented into United Kingdom, Germany, France, Italy ad Spain. Europe is the second largest market for monoclonal antibodies accounting for a share of approximately XX%. Within Europe, Germany is the largest market for monoclonal antibodies followed by United Kingdom.
Major companies dominating the Europe monoclonal antibodies market are GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel) and Ablynx NV (Belgium).
Segmentation
Based on Source :
Murine
Chimeric
Humanized
Human.
Based on Indication :
Cancer
Blood Cancer
Breast Cancer
Colorectal Cancer
Lung Cancer
Pancreatic Cancer
Others.
Autoimmune Diseases
Infectious Diseases
Cardiovascular Diseases
CNS Disorders
Others (Inflammatory, Microbial Diseases, & Other).
Based on End User :
Hospitals/Clinics
Research Institute
Diagnostic Laboratories.
Based on Application :
Medical
Experimental
Western Blot
ELISA
Radioimmune Assays
Immunofluorescence
Other (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry).
Based on geography, the report contains a wide array of countries covering all around the globe. Countries like USA, Mexico, U.K., Spain, Japan, Italy, India, China, South Africa, Israel and Brazil are identified as the predominant markets for Monoclonal Antibodies Market. For more of regional analysis, check out the following reports.
Asia-Pacific Monoclonal Antibodies Market
Europe Monoclonal Antibodies Market
Middle-East and Africa Monoclonal Antibodies
North America Monoclonal Antibodies Market
Latin America Monoclonal Antibodies Market
Some of the major companies dominating the market, by their products include GlaxoSmithKline plc. (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), Seattle Genetics (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel) and Shanghai Junshi Bioscience Co.,Ltd. (China). Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodies.
Scope of the Global Monoclonal Antibodies Market:
Global, Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the Global region
To detect major focus areas of industrial growth Segment-level analysis on basis of product on source, indication, application and end-user along with market size forecasts and y-o-y estimations are provided
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
PESTLE and Porters Five Forces Analyses that examine the macro & micro environmental factors such as political influence, technological prowess, industry rivalry to name a few.
An extensive listing of major market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
Expertly devised Market Outlook comprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the clients research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Global among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
View report: http://www.marketdataforecast.com/market-reports/europe-monoclonal-antibodies-market-1186/
MAb`s are antibodies produced by a single clone of cells consisting of identical antibody molecules. Monoclonal Antibodies have various diagnostic and therapeutic applications, especially in cancer. Apart from these mAb`s are also useful in protein purification. Growth in sales of currently approved monoclonal antibody products, along with 300 monoclonal antibody products currently in development, will show significant growth in sales of mAb products in the coming five years
Download free sample report: http://www.marketdataforecast.com/market-reports/europe-monoclonal-antibodies-market-1186/request-sample
Europe Monoclonal Antibodies market is driven by increasing Research and development activities, owing to introduction of advanced methods for mAb production. Major pharmaceutical companies are building their own product pipeline for the development of new molecules. Growing consumer awareness about various benefits and applications of mAb is also a major driving factor for the market growth. However huge cost and time associated with the identification and development, and stringent regulatory framework are the key restraining factors for the market growth.
Europe Monoclonal Antibodies is segmented by Source, Indication, End User and Application. On the basis of source market is categorized into Murine, Chimeric, Humanized and Human. By source Human mAb`s account for the largest share of the market. Based on Application the market is Segmented to cancer, Auto immune diseases, Infectious diseases, Cardiovascular diseases, CNS disorders and others. Cancer Vaccines are further sub segmented into Blood Cancer, Breast Cancer, Colorectal Cancer, Lung Cancer, Pancreatic Cancer and Others. On the basis of end user, the market is segmented into Hospitals/Clinics, Research Institute and Diagnostic Laboratories. Hospitals is the largest end user segment accounting for a share of approximately XX%. By application global monoclonal antibodies market is segmented into medical and experimental. Based on experimental the market is further sub segmented into Western Blot, ELISA, Radioimmune Assays, Immunofluorescence and others.
Inquire before buying: http://www.marketdataforecast.com/market-reports/europe-monoclonal-antibodies-market-1186/inquire
Geographically Europe monoclonal antibodies market is segmented into United Kingdom, Germany, France, Italy ad Spain. Europe is the second largest market for monoclonal antibodies accounting for a share of approximately XX%. Within Europe, Germany is the largest market for monoclonal antibodies followed by United Kingdom.
Major companies dominating the Europe monoclonal antibodies market are GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel) and Ablynx NV (Belgium).
Segmentation
Based on Source :
Murine
Chimeric
Humanized
Human.
Based on Indication :
Cancer
Blood Cancer
Breast Cancer
Colorectal Cancer
Lung Cancer
Pancreatic Cancer
Others.
Autoimmune Diseases
Infectious Diseases
Cardiovascular Diseases
CNS Disorders
Others (Inflammatory, Microbial Diseases, & Other).
Based on End User :
Hospitals/Clinics
Research Institute
Diagnostic Laboratories.
Based on Application :
Medical
Experimental
Western Blot
ELISA
Radioimmune Assays
Immunofluorescence
Other (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry).
Based on geography, the report contains a wide array of countries covering all around the globe. Countries like USA, Mexico, U.K., Spain, Japan, Italy, India, China, South Africa, Israel and Brazil are identified as the predominant markets for Monoclonal Antibodies Market. For more of regional analysis, check out the following reports.
Asia-Pacific Monoclonal Antibodies Market
Europe Monoclonal Antibodies Market
Middle-East and Africa Monoclonal Antibodies
North America Monoclonal Antibodies Market
Latin America Monoclonal Antibodies Market
Some of the major companies dominating the market, by their products include GlaxoSmithKline plc. (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), Seattle Genetics (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel) and Shanghai Junshi Bioscience Co.,Ltd. (China). Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodies.
Scope of the Global Monoclonal Antibodies Market:
Global, Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the Global region
To detect major focus areas of industrial growth Segment-level analysis on basis of product on source, indication, application and end-user along with market size forecasts and y-o-y estimations are provided
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
PESTLE and Porters Five Forces Analyses that examine the macro & micro environmental factors such as political influence, technological prowess, industry rivalry to name a few.
An extensive listing of major market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
Expertly devised Market Outlook comprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the clients research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Global among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results